Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America.

Goel R, Gribbons KB, Carette S, Cuthbertson D, Hoffman GS, Joseph G, Khalidi NA, Koening CL, Kumar S, Langford C, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Moreland LW, Nair A, Pagnoux C, Quinn KA, Ravindran R, Seo P, Sreih AG, Warrington KJ, Ytterberg SR, Merkel PA, Danda D, Grayson PC.

Rheumatology (Oxford). 2019 Oct 3. pii: kez421. doi: 10.1093/rheumatology/kez421. [Epub ahead of print]

PMID:
31580452
2.

Clinical Characteristics of Biopsy-Proven IgA Vasculitis in Children and Adults: A Retrospective Cohort Study.

Villatoro-Villar M, Crowson CS, Warrington KJ, Makol A, Ytterberg SR, Koster MJ.

Mayo Clin Proc. 2019 Sep;94(9):1769-1780. doi: 10.1016/j.mayocp.2019.04.034.

PMID:
31486380
3.

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis.

Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Quinn KA, Robson JC, Seo P, Sreih AG, Suppiah R, Warrington KJ, Ytterberg SR, Luqmani R, Watts R, Merkel PA, Grayson PC.

Arthritis Care Res (Hoboken). 2019 Aug 23. doi: 10.1002/acr.24055. [Epub ahead of print]

PMID:
31444857
4.

Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events.

Coffey CM, Richter MD, Crowson CS, Koster MJ, Warrington KJ, Ytterberg SR, Makol A.

J Rheumatol. 2019 Jun 15. pii: jrheum.181397. doi: 10.3899/jrheum.181397. [Epub ahead of print]

PMID:
31203225
5.

Reply.

Duarte-García A, Crowson CS, Warrington KJ, Matteson EL.

Arthritis Rheumatol. 2019 Oct;71(10):1769-1770. doi: 10.1002/art.41000. Epub 2019 Aug 29. No abstract available.

PMID:
31135097
6.

The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study.

Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, Warrington KJ, Matteson EL.

Arthritis Rheumatol. 2019 Sep;71(9):1545-1552. doi: 10.1002/art.40901. Epub 2019 Aug 1.

PMID:
30957430
7.

Occurrence and aetiology of gastrointestinal perforation in patients with vasculitis.

Kronzer VL, Larson DP, Crowson CS, Warrington KJ, Ytterberg SR, Makol A, Koster MJ.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):32-39. Epub 2019 Jan 9.

8.

Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.

Koster MJ, Yeruva K, Crowson CS, Muratore F, Labarca C, Warrington KJ.

J Rheumatol. 2019 May;46(5):501-508. doi: 10.3899/jrheum.180429. Epub 2019 Jan 15.

PMID:
30647171
9.

Isolated Thoracic Aortic Takayasu Arteritis Presenting as Presumed Mobile Aortic Thrombus.

Mirza AK, Saran N, Warrington KJ, Pochettino A, Shuja F.

Vasc Endovascular Surg. 2019 Apr;53(3):267-270. doi: 10.1177/1538574418823389. Epub 2019 Jan 3.

PMID:
30606091
10.

Arterial involvement in Erdheim-Chester disease: A retrospective cohort study.

Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, Go RS, Koster MJ.

Medicine (Baltimore). 2018 Dec;97(49):e13452. doi: 10.1097/MD.0000000000013452.

11.

Disease progression of Takayasu arteritis in two patients treated with tocilizumab.

Sanchez-Alvarez C, Koster M, Duarte-García A, Warrington KJ.

Ann Rheum Dis. 2018 Dec 8. pii: annrheumdis-2018-214642. doi: 10.1136/annrheumdis-2018-214642. [Epub ahead of print] No abstract available.

PMID:
30530823
12.

Smoking as a risk factor for giant cell arteritis: A systematic review and meta-analysis.

Brennan DN, Ungprasert P, Warrington KJ, Koster MJ.

Semin Arthritis Rheum. 2018 Dec;48(3):529-537. doi: 10.1016/j.semarthrit.2018.07.001. Epub 2018 Jul 11.

PMID:
30093239
13.

Large-vessel giant cell arteritis: diagnosis, monitoring and management.

Koster MJ, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii32-ii42. doi: 10.1093/rheumatology/kex424. Review.

PMID:
29982778
14.

Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.

Schäfer VS, Chrysidis S, Dejaco C, Duftner C, Iagnocco A, Bruyn GA, Carrara G, D'Agostino MA, De Miguel E, Diamantopoulos AP, Fredberg U, Hartung W, Hocevar A, Juche A, Kermani TA, Koster MJ, Lorenzen T, Macchioni P, Milchert M, Døhn UM, Mukhtyar C, Ponte C, Ramiro S, Scirè CA, Terslev L, Warrington KJ, Dasgupta B, Schmidt WA.

J Rheumatol. 2018 Aug;45(9):1289-1295. doi: 10.3899/jrheum.171428. Epub 2018 Jul 1.

PMID:
29961687
15.

Arterial lesions in giant cell arteritis: A longitudinal study.

Kermani TA, Diab S, Sreih AG, Cuthbertson D, Borchin R, Carette S, Forbess L, Koening CL, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Spiera RF, Warrington KJ, Ytterberg SR, Langford CA, Merkel PA, Khalidi NA; Vasculitis Clinical Research Consortium.

Semin Arthritis Rheum. 2019 Feb;48(4):707-713. doi: 10.1016/j.semarthrit.2018.05.002. Epub 2018 May 9.

16.

Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group.

Chrysidis S, Duftner C, Dejaco C, Schäfer VS, Ramiro S, Carrara G, Scirè CA, Hocevar A, Diamantopoulos AP, Iagnocco A, Mukhtyar C, Ponte C, Naredo E, De Miguel E, Bruyn GA, Warrington KJ, Terslev L, Milchert M, D'Agostino MA, Koster MJ, Rastalsky N, Hanova P, Macchioni P, Kermani TA, Lorenzen T, Døhn UM, Fredberg U, Hartung W, Dasgupta B, Schmidt WA.

RMD Open. 2018 May 17;4(1):e000598. doi: 10.1136/rmdopen-2017-000598. eCollection 2018.

17.

Prognosis and monitoring of giant cell arteritis and associated complications.

Kermani TA, Warrington KJ.

Expert Rev Clin Immunol. 2018 May;14(5):379-388. doi: 10.1080/1744666X.2018.1467758. Epub 2018 Apr 26. Review.

PMID:
29676201
18.

Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis.

Springer JM, Monach P, Cuthbertson D, Carette S, Khalidi NA, McAlear CA, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Hoffman G, Langford C, Hamilton T, Foell D, Vogl T, Holzinger D, Merkel PA, Roth J, Hajj-Ali RA.

J Clin Rheumatol. 2018 Oct;24(7):393-395. doi: 10.1097/RHU.0000000000000729. No abstract available.

19.

Impact of Medical Therapy on Late Morbidity and Mortality After Aortic Aneurysm Repair for Aortitis.

Prasad A, Helder MRK, Lahr BD, Dearani JA, Greason KL, Pochettino A, Warrington KJ, Connolly HM, Anavekar NS, Schaff HV.

Ann Thorac Surg. 2018 Jun;105(6):1731-1736. doi: 10.1016/j.athoracsur.2018.01.009. Epub 2018 Feb 2.

PMID:
29408240
20.

Spectrum of Aortic Disease in the Giant Cell Arteritis Population.

Kebed DT, Bois JP, Connolly HM, Scott CG, Bowen JM, Warrington KJ, Makol A, Greason KL, Schaff HV, Anavekar NS.

Am J Cardiol. 2018 Feb 15;121(4):501-508. doi: 10.1016/j.amjcard.2017.11.011. Epub 2017 Nov 23.

PMID:
29291886
21.

Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?

Muratore F, Kermani TA, Crowson CS, Koster MJ, Matteson EL, Salvarani C, Warrington KJ.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1406-1411. doi: 10.1002/acr.23498. Epub 2018 Aug 12.

22.

Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets.

Koster MJ, Warrington KJ.

BMC Rheumatol. 2017 Nov 28;1:2. doi: 10.1186/s41927-017-0004-5. eCollection 2017. Review.

23.

Evaluation of damage in giant cell arteritis.

Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

Rheumatology (Oxford). 2018 Feb 1;57(2):322-328. doi: 10.1093/rheumatology/kex397.

24.

Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.

Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Çikikçi C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ.

Rheumatology (Oxford). 2017 Nov 1;56(11):1939-1944. doi: 10.1093/rheumatology/kex300.

PMID:
28968808
25.

Vasculitis syndromes: Tocilizumab - a new frontier for GCA therapy.

Koster MJ, Warrington KJ.

Nat Rev Rheumatol. 2017 Dec;13(12):700-701. doi: 10.1038/nrrheum.2017.150. Epub 2017 Sep 7. No abstract available.

PMID:
28878334
26.

Classification of large vessel vasculitis: Can we separate giant cell arteritis from Takayasu arteritis?

Koster MJ, Warrington KJ.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e205-e213. doi: 10.1016/j.lpm.2016.11.032. Epub 2017 Jul 31.

PMID:
28774474
27.

Cardiopulmonary involvement in Takayasu's arteritis.

Brennan DN, Warrington KJ, Crowson CS, Schmidt J, Koster MJ.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):46-50. Epub 2017 Jun 12.

PMID:
28628465
28.

Is Routine Imaging of the Aorta Warranted in Patients With Giant Cell Arteritis?

Chen JJ, Warrington KJ, Garrity JA, Prasad S.

J Neuroophthalmol. 2017 Sep;37(3):314-319. doi: 10.1097/WNO.0000000000000538. Review. No abstract available.

PMID:
28614098
29.

Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.

Koster MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, Matteson EL, Warrington KJ.

J Rheumatol. 2017 Jul;44(7):1044-1050. doi: 10.3899/jrheum.161516. Epub 2017 May 1.

30.

Vasculitis of the mesenteric circulation.

Koster MJ, Warrington KJ.

Best Pract Res Clin Gastroenterol. 2017 Feb;31(1):85-96. doi: 10.1016/j.bpg.2016.12.003. Epub 2017 Jan 5. Review.

PMID:
28395792
31.

Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.

Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, Weyand CM.

Mod Pathol. 2017 Jun;30(6):788-796. doi: 10.1038/modpathol.2017.10. Epub 2017 Mar 3.

32.

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.

Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 Apr;69(4):846-853. doi: 10.1002/art.40037. Epub 2017 Mar 8.

33.

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 Apr;69(4):837-845. doi: 10.1002/art.40044. Epub 2017 Mar 3.

34.

Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.

Zhang H, Watanabe R, Berry GJ, Vaglio A, Liao YJ, Warrington KJ, Goronzy JJ, Weyand CM.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E970-E979. doi: 10.1073/pnas.1616848114. Epub 2017 Jan 23.

35.

Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.

Ungprasert P, Koster MJ, Warrington KJ, Matteson EL.

Rheumatol Int. 2017 Jan;37(1):143-149. doi: 10.1007/s00296-016-3557-5. Epub 2016 Aug 30. Review.

PMID:
27577940
36.

Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.

Ungprasert P, Koster MJ, Thongprayoon C, Warrington KJ.

Clin Rheumatol. 2016 Nov;35(11):2741-2747. Epub 2016 Aug 30. Review.

PMID:
27572522
37.

Clinical Spectrum of Medium-Sized Vessel Vasculitis.

Alibaz-Oner F, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Salvarani C, Matteson EL, Warrington KJ.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):884-891. doi: 10.1002/acr.23007. Epub 2017 Apr 24.

38.

Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies.

Ungprasert P, Wijarnpreecha K, Koster MJ, Thongprayoon C, Warrington KJ.

Semin Arthritis Rheum. 2016 Dec;46(3):361-366. doi: 10.1016/j.semarthrit.2016.07.005. Epub 2016 Jul 21. Review.

PMID:
27546492
39.

Recent advances in understanding and treating vasculitis.

Koster MJ, Warrington KJ.

F1000Res. 2016 Jun 20;5. pii: F1000 Faculty Rev-1436. doi: 10.12688/f1000research.8403.1. eCollection 2016. Review.

40.

Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.

Chen JJ, Leavitt JA, Fang C, Crowson CS, Matteson EL, Warrington KJ.

Ophthalmology. 2016 Sep;123(9):1999-2003. doi: 10.1016/j.ophtha.2016.05.008. Epub 2016 Jun 11.

41.

Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis.

Kermani TA, Warrington KJ, Crowson CS, Hunder GG, Ytterberg SR, Gabriel SE, Matteson EL.

J Clin Rheumatol. 2016 Jun;22(4):184-7. doi: 10.1097/RHU.0000000000000381.

PMID:
27219304
42.

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.

Kermani TA, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McKinnon-Maksimowicz K, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Matteson EL; Vasculitis Clinical Research Consortium.

J Rheumatol. 2016 Jun;43(6):1078-84. doi: 10.3899/jrheum.151063. Epub 2016 Apr 1.

43.

Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.

Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, Salvarani C, Matteson EL, Warrington KJ.

PLoS One. 2016 Feb 22;11(2):e0149579. doi: 10.1371/journal.pone.0149579. eCollection 2016.

44.

Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis.

Koster MJ, Matteson EL, Warrington KJ.

Curr Opin Rheumatol. 2016 May;28(3):211-7. doi: 10.1097/BOR.0000000000000265. Review.

PMID:
26885650
45.

Retrospective Comparison of Open versus Endovascular Procedures for Takayasu Arteritis.

Labarca C, Makol A, Crowson CS, Kermani TA, Matteson EL, Warrington KJ.

J Rheumatol. 2016 Feb;43(2):427-32. doi: 10.3899/jrheum.150447. Epub 2015 Dec 15.

PMID:
26669920
46.

Pulmonary IgG4-related disease and colon adenocarcinoma: possible paraneoplastic syndrome.

Krause ML, Yi ES, Warrington KJ.

Int J Rheum Dis. 2017 May;20(5):654-656. doi: 10.1111/1756-185X.12806. Epub 2015 Dec 1.

PMID:
26620534
47.

Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.

Ungprasert P, Thongprayoon C, Warrington KJ.

Ann Transl Med. 2015 Sep;3(16):232. doi: 10.3978/j.issn.2305-5839.2015.09.31.

48.

Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.

Labarca C, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2016 Feb;55(2):347-56. doi: 10.1093/rheumatology/kev348. Epub 2015 Sep 18.

49.

Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.

Ungprasert P, Upala S, Sanguankeo A, Warrington KJ.

Mod Rheumatol. 2016;26(3):410-4. doi: 10.3109/14397595.2015.1081722. Epub 2015 Sep 18. Review.

PMID:
26381748
50.

Concomitant giant cell arteritis and secondary adrenal insufficiency.

Krause ML, Norgan A, Vella A, Beckman TJ, Warrington KJ.

Scand J Rheumatol. 2015;44(6):517-9. doi: 10.3109/03009742.2015.1046913. Epub 2015 Jul 14. No abstract available.

PMID:
26169623

Supplemental Content

Loading ...
Support Center